1,190,954 Shares in LifeStance Health Group, Inc. $LFST Acquired by Jacobs Levy Equity Management Inc.

Jacobs Levy Equity Management Inc. purchased a new position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 1,190,954 shares of the company's stock, valued at approximately $7,932,000. Jacobs Levy Equity Management Inc. owned approximately 0.31% of LifeStance Health Group as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. DekaBank Deutsche Girozentrale purchased a new stake in LifeStance Health Group in the 1st quarter worth $31,000. Xponance Inc. purchased a new stake in LifeStance Health Group in the 1st quarter worth $69,000. Ameriprise Financial Inc. purchased a new stake in LifeStance Health Group in the 4th quarter worth $87,000. Kapitalo Investimentos Ltda purchased a new stake in LifeStance Health Group in the 1st quarter worth $87,000. Finally, Forum Financial Management LP acquired a new stake in LifeStance Health Group during the 4th quarter worth $110,000. Hedge funds and other institutional investors own 85.50% of the company's stock.

LifeStance Health Group Trading Down 2.1%

LFST traded down $0.11 on Friday, hitting $5.23. The company had a trading volume of 1,246,590 shares, compared to its average volume of 2,071,969. The firm has a market cap of $2.03 billion, a P/E ratio of -104.60 and a beta of 1.17. LifeStance Health Group, Inc. has a 1 year low of $3.74 and a 1 year high of $8.61. The company's fifty day moving average price is $4.81 and its 200 day moving average price is $5.74. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.19.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.02. The firm had revenue of $345.31 million for the quarter, compared to analyst estimates of $345.05 million. LifeStance Health Group had a negative net margin of 1.23% and a negative return on equity of 1.11%. LifeStance Health Group's revenue was up 10.6% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.06) EPS. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities analysts expect that LifeStance Health Group, Inc. will post -0.18 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on LFST. UBS Group lifted their target price on shares of LifeStance Health Group from $8.50 to $9.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. BTIG Research began coverage on shares of LifeStance Health Group in a research note on Friday, July 25th. They set a "buy" rating and a $8.00 target price on the stock. Finally, Wall Street Zen raised shares of LifeStance Health Group from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, LifeStance Health Group presently has a consensus rating of "Moderate Buy" and an average price target of $8.50.

Insider Activity at LifeStance Health Group

In related news, major shareholder Summit Partners L. P sold 8,407,643 shares of the business's stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $5.07, for a total value of $42,626,750.01. Following the sale, the insider directly owned 33,524,715 shares in the company, valued at approximately $169,970,305.05. The trade was a 20.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Silversmith Partners I. Gp, Llc sold 3,592,357 shares of the business's stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $5.07, for a total transaction of $18,213,249.99. Following the completion of the sale, the insider owned 14,324,197 shares in the company, valued at approximately $72,623,678.79. This trade represents a 20.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 20,407,643 shares of company stock worth $103,466,750. Company insiders own 3.20% of the company's stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.